Biomarin Pharmaceutical - Registered Shares Common Stock

As of the most recent data (September 2026), BMRN shows a common stock of $190K. That compares with $-11M in the prior-year period — up 101.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMRN's common stock is now $190K (was $-11M) — a 101.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biomarin Pharmaceutical - Registered Shares is outperforming or lagging.

Tracking BMRN's common stock over time shows whether Biomarin Pharmaceutical - Registered Shares is scaling, shrinking, or reshaping that part of the business. The current reading is $190K That compares with $-11M in the prior-year period — up 101.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Biomarin Pharmaceutical - Registered Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $190K) with ownership activity and broader fundamentals.

Biomarin Pharmaceutical - Registered Shares's common stock is $190K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.